Bene Vobis MCT coconut oil 500 ml

The Bene Vobis Coconut MCT Oil dietary supplement is a high-quality product containing valuable MCT oil from coconuts. This oil is a treasure trove of many active ingredients with health-promoting properties, such as caproic, caprylic, capric, lauric, myristic, and palmitic acids. The Bene Vobis product has a simple composition, free of any additives, preservatives, flavor enhancers, or colorings.

MCTs are medium-chain saturated fats consisting of 6-10 carbon atoms. They are found primarily in coconut palms. These fats are metabolized in the liver and not absorbed in the intestines like other fats.

The caprylic acid contained in MCTs can help reduce feelings of hunger. It is involved in the acylation of ghrelin, which is widely known as the hunger hormone due to its orexogenic effects. [1]

Medium-chain fatty acids contribute to lowering LDL levels and increasing HDL levels. This effect has been shown to be comparable to that of olive oil. [2]

MCT supplementation may improve cognitive function. Caprylic acid has been shown to contribute to the restoration of cognitive function in individuals who have experienced cognitive decline. [3]

In summary, Bene Vobis Coconut MCT Oil is a high-quality product that provides valuable MCT oil from coconuts. This substance has numerous health benefits. The Bene Vobis product has the advantage of a pure, simple composition without any additives and a liquid form that is convenient to use.

1 Lemarié F, Beauchamp E, Legrand P, Rioux V. Review of the metabolism and physiological functions of caprylic acid (C8:0) with particular attention to ghrelin acetylation. Biochimie. 2016 Jan;120:40-8. doi: 10.1016/j.biochi.2015.08.002. Epub 2015 Aug 4. PMID: 26253695.

2 St-Onge MP, Bosarge A, Goree LL, Darnell B. Medium chain triglyceride oil consumption as part of a weight loss diet does not lead to an adverse metabolic profile when compared to olive oil. J Am Coll Nutr. 2008 Oct;27(5):547-52. doi: 10.1080/07315724.2008.10719737. PMID: 18845704; PMCID: PMC2874191.

3 Henderson ST, Vogel JL, Barr LJ, Garvin F, Jones JJ, Costantini LC. Study of the ketogenic drug AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial. Nutr Metab (London). 2009 Aug 10;6:31. doi: 10.1186/1743-7075-6-31. PMID: 19664276; PMCID: PMC2731764.